Luteinizing hormone releasing hormone antagonist peptides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 14, 1996
Grant Date -
N/A
app pub date -
Jan 17, 1994
filing date -
Apr 25, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A luteinizing hormone releasing hormone antagonist peptide is provided which effectively decreases plasma levels of estrogens and androgens. The peptide exhibits increased levels of potency while at the same time minimizing histamine releasing properties, vascular permeability (or edematogenic effects), hypotension, poor water solubility an inadequate duration of action associated with luteinizing hormone releasing hormone antagonist peptides of the past.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully